Sonia Cohen

3.7k total citations · 2 hit papers
31 papers, 2.3k citations indexed

About

Sonia Cohen is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Sonia Cohen has authored 31 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 11 papers in Oncology and 11 papers in Genetics. Recurrent topics in Sonia Cohen's work include Genetics and Neurodevelopmental Disorders (9 papers), Melanoma and MAPK Pathways (6 papers) and Cutaneous Melanoma Detection and Management (5 papers). Sonia Cohen is often cited by papers focused on Genetics and Neurodevelopmental Disorders (9 papers), Melanoma and MAPK Pathways (6 papers) and Cutaneous Melanoma Detection and Management (5 papers). Sonia Cohen collaborates with scholars based in United States, Netherlands and Australia. Sonia Cohen's co-authors include Michael E. Greenberg, Linda Hu, Zhaolan Zhou, David D. Ginty, Bonnie E. Lonze, Yingxi Lin, Wen Chen, Judith A. Steen, Hsin‐Yi Henry Ho and Elizabeth J. Hong and has published in prestigious journals such as Nature, Neuron and Journal of Clinical Oncology.

In The Last Decade

Sonia Cohen

25 papers receiving 2.3k citations

Hit Papers

Brain-Specific Phosphorylation of MeCP2 Regulates Activit... 2006 2026 2012 2019 2006 2024 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sonia Cohen United States 15 1.4k 1.1k 639 615 269 31 2.3k
Chiara Verpelli Italy 30 1.5k 1.1× 856 0.8× 939 1.5× 565 0.9× 191 0.7× 56 2.6k
Luis de la Torre-Ubieta United States 22 2.3k 1.7× 1.2k 1.1× 355 0.6× 680 1.1× 229 0.9× 29 3.3k
Gregory B. Potter United States 18 1.2k 0.9× 534 0.5× 910 1.4× 406 0.7× 633 2.4× 19 2.4k
Emily K. Osterweil United States 19 1.8k 1.3× 1.8k 1.7× 696 1.1× 1.3k 2.1× 199 0.7× 28 3.2k
Geeske M. van Woerden Netherlands 25 1.3k 1.0× 1.0k 0.9× 715 1.1× 391 0.6× 132 0.5× 49 2.3k
Hsien‐Sung Huang United States 18 1.8k 1.3× 1.1k 0.9× 518 0.8× 387 0.6× 181 0.7× 34 2.5k
Chang‐Hyuk Kwon United States 17 1.6k 1.2× 625 0.6× 625 1.0× 466 0.8× 624 2.3× 19 3.0k
Rosanna Parlato Germany 28 1.5k 1.0× 428 0.4× 879 1.4× 174 0.3× 196 0.7× 63 2.4k
Diana Yu United States 14 2.0k 1.4× 617 0.6× 700 1.1× 349 0.6× 460 1.7× 23 2.7k

Countries citing papers authored by Sonia Cohen

Since Specialization
Citations

This map shows the geographic impact of Sonia Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sonia Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sonia Cohen more than expected).

Fields of papers citing papers by Sonia Cohen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sonia Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sonia Cohen. The network helps show where Sonia Cohen may publish in the future.

Co-authorship network of co-authors of Sonia Cohen

This figure shows the co-authorship network connecting the top 25 collaborators of Sonia Cohen. A scholar is included among the top collaborators of Sonia Cohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sonia Cohen. Sonia Cohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oliveira, Solange, Nayara Gusmão Tessarollo, Ana Paula Lepique, et al.. (2025). Use of patient-derived organotypic tumor spheroids for testing of viral vector gene therapy in combination with checkpoint blockade. PubMed. 33(1). 200942–200942. 1 indexed citations
2.
Lawless, Aleigha, Tatyana Sharova, Alexander M. Menzies, et al.. (2025). Real‐World Outcomes of Adjuvant Therapy in Stage III Melanoma and the Impact of Somatic Mutations. Cancer Medicine. 14(23). e71410–e71410.
4.
Sierra-Davidson, Kailan, Aikaterini Dedeilia, Aleigha Lawless, et al.. (2024). Genetic Factors Associated with Clinical Response in Melanoma Patients Treated with Talimogene Laherparapvec: A Single-Institution Retrospective Analysis. Annals of Surgical Oncology. 32(1). 482–494. 2 indexed citations
5.
Sierra-Davidson, Kailan, Aikaterini Dedeilia, Aleigha Lawless, et al.. (2024). ASO Visual Abstract: Genetic Factors Associated with Clinical Response in Melanoma Patients Treated with Talimogene Laherparepvec—A Single-Institution Retrospective Analysis. Annals of Surgical Oncology. 32(4). 2773–2774.
6.
Goldberg, Saveli, Sonia Cohen, Shannon M. MacDonald, et al.. (2024). Preoperative Radiation Therapy is Not Associated with Postoperative Complications in Patients with Retroperitoneal Sarcoma. Annals of Surgical Oncology. 32(3). 1522–1528. 1 indexed citations
7.
Holder, Ashley M., Aikaterini Dedeilia, Kailan Sierra-Davidson, et al.. (2024). Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours. Nature reviews. Cancer. 24(7). 498–512. 112 indexed citations breakdown →
8.
Leung, Bonnie W., Guihong Wan, Wenxin Chen, et al.. (2023). Increased risk of cutaneous immune-related adverse events in patients treated with talimogene laherparepvec and immune checkpoint inhibitors: A multi-hospital cohort study. Journal of the American Academy of Dermatology. 88(6). 1265–1270. 3 indexed citations
9.
Shalhout, Sophia Z., et al.. (2022). Ipi/Nivo for Advanced MCC. 1(1).
10.
Molina, George, et al.. (2020). Mixed Response to Immunotherapy in Patients with Metastatic Melanoma. Annals of Surgical Oncology. 27(9). 3488–3497. 23 indexed citations
11.
Cohen, Sonia & Liliana Bordeianou. (2019). Continued Improvement in Rectal Cancer Survival Outcomes Will Require True Multidisciplinary Treatment Approaches. Journal of Gastrointestinal Surgery. 24(3). 742–747. 3 indexed citations
12.
Raigani, Siavash, Sonia Cohen, & Genevieve M. Boland. (2017). The Role of Surgery for Melanoma in an Era of Effective Systemic Therapy. Current Oncology Reports. 19(3). 17–17. 23 indexed citations
13.
Ebert, Daniel H., Harrison W. Gabel, Nathaniel D. Robinson, et al.. (2013). Activity-dependent phosphorylation of MeCP2 threonine 308 regulates interaction with NCoR. Nature. 499(7458). 341–345. 167 indexed citations
14.
Ross, Sarah E., Alejandra E. McCord, Cynthia C. Jung, et al.. (2012). Bhlhb5 and Prdm8 Form a Repressor Complex Involved in Neuronal Circuit Assembly. Neuron. 73(2). 292–303. 95 indexed citations
15.
Goffin, Darren, Megan Allen, Le Zhang, et al.. (2011). Rett syndrome mutation MeCP2 T158A disrupts DNA binding, protein stability and ERP responses. Nature Neuroscience. 15(2). 274–283. 172 indexed citations
16.
Cohen, Sonia, Harrison W. Gabel, Martin Hemberg, et al.. (2011). Genome-Wide Activity-Dependent MeCP2 Phosphorylation Regulates Nervous System Development and Function. Neuron. 72(1). 72–85. 235 indexed citations
17.
Zhou, Zhaolan, Elizabeth J. Hong, Sonia Cohen, et al.. (2006). Brain-Specific Phosphorylation of MeCP2 Regulates Activity-Dependent Bdnf Transcription, Dendritic Growth, and Spine Maturation. Neuron. 52(2). 255–269. 677 indexed citations breakdown →
18.
Kaufmann, Walter E., et al.. (2002). Molecular phenotype of Fragile X syndrome: FMRP, FXRPs, and protein targets. Microscopy Research and Technique. 57(3). 135–144. 19 indexed citations
19.
Lonze, Bonnie E., et al.. (2002). Apoptosis, Axonal Growth Defects, and Degeneration of Peripheral Neurons in Mice Lacking CREB. Neuron. 34(3). 371–385. 279 indexed citations
20.
Cohen, Sonia, et al.. (2001). Annexin-1 is abnormally expressed in Fragile X syndrome: Two-dimensional electrophoresis study in lymphocytes. American Journal of Medical Genetics. 103(1). 81–90. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026